If Elected, Biden Could Face Tough Choices on New Waivers

With the 2020 election drawing ever closer, the Trump administration has been approving states’ waiver applications at a brisk pace — greenlighting Georgia’s Section 1115 Medicaid waiver on Oct. 15, and another Medicaid waiver from Nebraska on Oct. 20. Further, CMS has said that it’s on the cusp of approving Georgia’s unique plan to remake its individual insurance market.

Health policy experts tell AIS Health that the fate of the three waiver programs depends not only on who wins the White House on Nov. 3, but also on the outcome of a case pending before the Supreme Court. They also say that if former Vice President Joe Biden is elected, states may have to think about waivers very differently than they have under the Trump administration.

0 Comments
© 2025 MMIT
Leslie Small

Leslie Small

Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

Related Posts

supreme-court
October 4

Will Supreme Court Review Preventive Services Coverage Case?

READ MORE
wall-street-sign
October 4

Unsurprising or Unlikely? Analysts React to Prospect of CVS Breakup

READ MORE
medicare-advantage-sign
October 4

MA Star Ratings Drama: Humana Gets Bad News, UnitedHealth Sues CMS

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today